Xultophy is a prescription medication used in the treatment of type 2 diabetes. It is a combination of two active ingredients: insulin degludec, a long-acting insulin, and liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. This combination works by providing both the benefits of insulin, which helps to lower blood sugar levels, and liraglutide, which enhances the body's natural ability to control blood glucose. Xultophy is administered via injection and is typically recommended for adults with type 2 diabetes when their condition cannot be adequately controlled with oral medications alone. It is designed to improve blood sugar control throughout the day, including after meals, and can also have a positive effect on weight management in some patients. As with any medication, the use of Xultophy should be under the guidance of a healthcare professional, and it is important for patients to follow their doctor's instructions regarding dosage and administration.